A Self-controlled Trial of Prophylactic Topical Application of Vitamin K1 Cream for Cetuximab-related Skin Rash -VANQUISH trial-

ABSTRACT: Interventions: Vitamin K1 cream Plcebo cream Primary outcome(s): The incidence of grade2-5 rash acneiform (CTCAE v4.0) of face whithin 4 weeks from starting cetuximab containing chemotherapy Study Design: Parallel Randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2625669 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR